PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Clinical trial NCT05518110 · TERMINATED
Trial details
- NCT number
- NCT05518110
- Sponsor
- Cancer Trials Ireland
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2026-03-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.